Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
2cureX ABOSTO:2CUREX +1.74%29 Market Cap is kr46.99 Mil as of Jul. 21, 2026. GuruFocus rates OSTO:2CUREX with a GF Score™ of 29/100. The stock has 3 warning signs investors should review. Among 1,423 Biotechnology companies, 2cureX AB ranks worse than 91.29% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). 2cureX AB's share price for the quarter that ended in Jun. 2025 was kr3.13. 2cureX AB's Shares Outstanding (EOP) for the quarter that ended in Jun. 2025 was 25.10 Mil. Therefore, 2cureX AB's market cap for the quarter that ended in Jun. 2025 was kr78.57 Mil.
2cureX AB's quarterly market cap
increased
from Jun. 2024 (kr8.63 Mil) to Dec. 2024 (kr10.59 Mil) and
increased
from Dec. 2024 (kr10.59 Mil) to Jun. 2025 (kr78.57 Mil).
2cureX AB's annual market cap
declined
from Dec. 2022 (kr143.46 Mil) to Dec. 2023 (kr35.38 Mil) and
declined
from Dec. 2023 (kr35.38 Mil) to Dec. 2024 (kr10.59 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. 2cureX AB's Enterprise Value for Today is kr41.90 Mil.
2cureX AB (OSTO:2CUREX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
2cureX AB Market Cap Related Terms
2cureX AB Market Cap Historical Data
* Premium members only.
The historical data trend for 2cureX AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:2CUREX vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, 2cureX AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
2cureX AB Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 2cureX AB's Market Cap distribution charts can be found below:
* The bar in red indicates where 2cureX AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
2cureX AB's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
2cureX AB (OSTO:2CUREX) has a Market Cap of kr46.99 Mil as of Jul. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on 2cureX AB and its competitors. According to the industry distribution chart, 2cureX AB ranks #1299 out of 1423 companies in the Biotechnology industry, placing it in the top 91.3%.
Is 2cureX AB's Market Cap too high?
2cureX AB's current Market Cap is kr46.99 Mil. Based on the distribution chart, 2cureX AB ranks #1299 out of 1423 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, 2cureX AB has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does 2cureX AB's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, 2cureX AB ranks #1299 out of 1423 companies for Market Cap. This places 2cureX AB in the lower half of its industry. The industry median Market Cap is 111.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 111.61, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on 2cureX AB and its competitors. For the Biotechnology industry, the median Market Cap is 111.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 2cureX AB's current Market Cap is kr46.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 2cureX AB stock overvalued right now?
2cureX AB (OSTO:2CUREX) has a current Market Cap of kr46.99 Mil. The current Market Cap is kr46.99 Mil. 2cureX AB's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For 2cureX AB (OSTO:2CUREX), the current Market Cap is kr46.99 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.
29GF Score
Get the complete analysis for OSTO:2CUREX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:2CUREX has been successfully added to your 
